(Q54656705)
Statements
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging. (English)
1 reference
1 reference
A-M C Dingemans
1 reference
A J de Langen
1 reference
V van den Boogaart
1 reference
J T Marcus
1 reference
W H Backes
1 reference
H T G M Scholtens
1 reference
H van Tinteren
1 reference
O S Hoekstra
1 reference
J Pruim
1 reference
B Brans
1 reference
E F Smit
1 reference
H J M Groen
1 reference
11 August 2010
1 reference
22
1 reference
559-566
1 reference
3
1 reference
Identifiers
1 reference